CELH
Celsius Holdings, Inc.
CELH has the edge over UVV overall, supported by stronger fundamentals and stronger valuation.
UVV
Universal Corporation
UVV has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
UVV Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
UVV's revenue, profitability, cash flow and balance sheet are all currently under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
UVV PE Valuation
UVV has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over UVV on the outlook, with more favorable earnings and revenue expectations.
UVV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect UVV's earnings, revenue and profitability to hold roughly steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over UVV on earnings quality, reporting a profit while its opponent remains loss making.
UVV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.91 | — |
| Q3 2026 | -$0.10 | -102% |
| Q2 2026 | $0.76 | -82% |
| Q1 2026 | $1.30 | -66% |
| Q4 2025 | $3.39 | -33% |
| Q3 2025 | $4.44 | -7.1% |
| Q2 2025 | $4.11 | -16% |
| Q1 2025 | $3.78 | -21% |
| Q4 2024 | $5.03 | -5.3% |
UVV has swung to a loss: it lost $0.10 per share over the past year, after a profit the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over UVV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over UVV on profitability, with a higher operating margin.
UVV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $617.4M | -18% |
| Q2 2026 | $520.3M | -12% |
| Q1 2026 | $689.9M | 0% |
| Q4 2025 | $853.2M | -8.1% |
| Q3 2025 | $749.4M | +5.8% |
| Q2 2025 | $592.6M | -0.6% |
| Q1 2025 | $690.2M | -8.7% |
| Q4 2024 | $928M | +14% |
UVV's revenue has slid since its 2024 peak: $617M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.9% | -2.1 points |
| Q2 2026 | 0.4% | -5.3 points |
| Q1 2026 | -2.2% | -8.4 points |
| Q4 2025 | 9.6% | -1.6 points |
| Q3 2025 | 9% | -0.7 points |
| Q2 2025 | 5.7% | +2.8 points |
| Q1 2025 | 6.2% | -2.8 points |
| Q4 2024 | 11% | +0.5 points |
UVV's operating margin was 6.9% last quarter, down 2.1 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
UVV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$116.3M | -591% |
| Q2 2026 | -$133M | +$84.1M |
| Q1 2026 | $178.6M | +18% |
| Q4 2025 | $95.1M | -52% |
| Q3 2025 | $23.7M | +$24.7M |
| Q2 2025 | -$217.2M | -$132M |
| Q1 2025 | $151M | +$197.2M |
| Q4 2024 | $199.6M | +$271.9M |
UVV has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over UVV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
UVV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +152K shares |
| 1 year | +0.2% | +54.9K shares |
| 3 years | +0.9% | +218K shares |
| 5 years | +1.3% | +317K shares |
| Available history | +0.7% | +178K shares |
UVV has 25M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.3M |
| Q2 2026 | $2.7M |
| Q1 2025 | — |
| Q4 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over UVV on leverage, with a lower net debt burden relative to earnings.
UVV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.0x | High |
| Q2 2026 | 5.3x | High |
| Q1 2026 | 3.8x | Elevated |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 3.0x | Moderate |
UVV's net debt is about 7.0 years of its operating earnings (EBITDA), up from 3.5 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
UVV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.1 | Oversold |
| Stochastic | 9.9 | Oversold |
UVV's weekly RSI is 26 (oversold) and its Stochastic is 10 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over UVV on valuation relative to its sector.
UVV PE vs Consumer Defensive Sector
| Metric | UVV | Sector median | Relative |
|---|---|---|---|
| PE | 55x | 19x | 180% above |
| PE % | 97 | 18 | 79 pts above |
UVV has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over UVV on trend strength, trading above more of its moving averages.
UVV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.7 | 7.2% below |
| 20 week MA | $45.5 | 17% below |
| 50 week MA | $50.4 | 25% below |
| 100 week MA | $52.7 | 28% below |
| 200 week MA | $52.4 | 28% below |
UVV is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
UVV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.6 | $48.6 | -14% |
| 2021 | $48.6 | $53.8 | +11% |
| 2022 | $53.8 | $53.8 | 0% |
| 2023 | $53.8 | $67.3 | +25% |
| 2024 | $67.3 | $54.3 | -19% |
| 2025 | $54.3 | $53.2 | -2.2% |
| 2026 YTD | $53.2 | $37.7 | -29% |
UVV has the edge over CELH on returns for 2026, with the stronger performance.